Acurx Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Acurx Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2020 to 2022.
  • Acurx Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000.
  • Acurx Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2023-03-15
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.